Country: United Kingdom
Language: English
Source: VMD (Veterinary Medicines Directorate)
Furosemide
MSD Animal Health UK Limited
QC03CA01
Furosemide
Solution for injection
POM-V - Prescription Only Medicine – Veterinarian
Cats, Cattle, Dogs, Horses
Cardio Vascular diuretic
Authorized
2005-04-27
Revised: December 2020 AN: 01394/2020 Page 1 of 6 SUMMMARY OF PRODUCT CHARACTERISTICS 1. NAME OF THE VETERINARY MEDICINAL PRODUCT Dimazon 50 mg/ml solution for injection 2. QUALITATIVE AND QUANTITATIVE COMPOSITION Each ml contains: ACTIVE SUBSTANCE: Furosemide 50.0 mg (as monoethanolamine salt) EXCIPIENTS: Benzyl alcohol 15.0 mg Disodium edetate 1.0 mg Sodium sulfite, anhydrous 1.8 mg For the full list of excipients, see section 6.1 3. PHARMACEUTICAL FORM Solution for injection. A clear, yellowish fluid. 4. CLINICAL PARTICULARS 4.1 TARGET SPECIES Cattle, horses, cats and dogs. 4.2 INDICATIONS FOR USE, SPECIFYING THE TARGET SPECIES A potent saluretic type of diuretic for parenteral administration to cattle, horses, cats and dogs. Dimazon is indicated in the treatment of oedemata associated with cardiac insufficiency, renal dysfunction, trauma and parasitic disease. It is also recommended for the treatment of mammary oedema and limb oedemata. The product gives rapid onset of diuretic action with increased sodium and water excretion. It is even effective where glomerular filtration is impaired. 4.3 CONTRA-INDICATIONS Do not use in cases of acute glomerular nephritis renal failure with anuria, electrolyte deficiency disease or overdosage with digitalis. Do not use concurrently with aminoglycoside antibiotic treatment. The therapeutic effect may be impaired by increased intake of drinking water. So Revised: December 2020 AN: 01394/2020 Page 2 of 6 far as the patient's condition allows, the amount of drinking water should be restricted. Do not use in cases of hypersensitivity to the active substance or to any of the excipients. 4.4 SPECIAL WARNING FOR EACH TARGET SPECIES Clinical experience with dogs indicates that improved results can frequently be achieved by supplementary administration of corticosteroids. 4.5 SPECIAL PRECAUTIONS FOR USE Special precautions for use in animals In pulmonary oedema of cardiac origin, combined therapy with cardiac glycosides is advisable. Only during prolonged treatment is it necessary Read the complete document